Suchergebnisse
Katalog
Aufsätze & mehr
Suchmaske
Suchergebnisse einschränken oder erweitern
Aktive Suchfilter
Weniger Treffer
Art der Quelle
Thema
- piperazines 12 Treffer
- leukemia, myelogenous, chronic, bcr-abl positive 7 Treffer
- pyrazoles 7 Treffer
- antineoplastic agents 6 Treffer
- drug resistance, neoplasm 4 Treffer
-
45 weitere Werte:
- fusion proteins, bcr-abl 4 Treffer
- leukemia, lymphocytic, chronic, b-cell 3 Treffer
- protein kinase inhibitors 3 Treffer
- protein-tyrosine kinases 3 Treffer
- thiazoles 3 Treffer
- agammaglobulinaemia tyrosine kinase 2 Treffer
- enzyme inhibitors 2 Treffer
- graft vs host disease 2 Treffer
- leukemia 2 Treffer
- lymphoma, large b-cell, diffuse 2 Treffer
- neoplasm recurrence, local 2 Treffer
- philadelphia chromosome 2 Treffer
- proto-oncogene proteins c-kit 2 Treffer
- sulfonamides 2 Treffer
- anemia 1 Treffer
- antineoplastic combined chemotherapy protocols 1 Treffer
- aspergillosis 1 Treffer
- aspergillus fumigatus 1 Treffer
- benzamides 1 Treffer
- blast crisis 1 Treffer
- bone morphogenetic protein receptors, type i 1 Treffer
- bridged bicyclo compounds, heterocyclic 1 Treffer
- ccaat-enhancer-binding proteins 1 Treffer
- chromosome aberrations 1 Treffer
- class i phosphatidylinositol 3-kinases 1 Treffer
- cyclopentanes 1 Treffer
- diphosphonates 1 Treffer
- dna damage 1 Treffer
- dna repair 1 Treffer
- drug synergism 1 Treffer
- gene expression regulation, enzymologic 1 Treffer
- gene expression regulation, leukemic 1 Treffer
- hematopoietic stem cell transplantation 1 Treffer
- hepcidins 1 Treffer
- histone deacetylase inhibitors 1 Treffer
- hydrazines 1 Treffer
- hydroxamic acids 1 Treffer
- imidazoles 1 Treffer
- intracellular signaling peptides and proteins 1 Treffer
- leukemia, myeloid 1 Treffer
- leukemia, myeloid, acute 1 Treffer
- leukemia, myeloid, chronic-phase 1 Treffer
- lymphoma, follicular 1 Treffer
- macrophages 1 Treffer
- map kinase kinase 1 1 Treffer
Sprache
Inhaltsanbieter
25 Treffer
-
In: Blood, Jg. 132 (2018-11-01), Heft 18, S. 1985reportZugriff:
-
In: Blood, Jg. 129 (2017-03-30), Heft 13, S. 1823academicJournalZugriff:
-
In: Blood, Jg. 119 (2012-04-26), Heft 17, S. 4083academicJournalZugriff:
-
In: Blood, Jg. 117 (2011-03-24), Heft 12, S. 3409academicJournalZugriff:
-
In: Blood, Jg. 101 (2003-01-15), Heft 2, S. 664academicJournalZugriff:
-
In: Blood, Jg. 101 (2003-01-15), Heft 2, S. 655academicJournalZugriff:
-
In: Blood, Jg. 141 (2023-03-02), Heft 9, S. 971academicJournalZugriff:
-
In: Blood, Jg. 133 (2019-01-03), Heft 1, S. 70academicJournalZugriff:
-
In: Blood, Jg. 131 (2018-04-19), Heft 16, S. 1805academicJournalZugriff:
-
In: Blood, Jg. 131 (2018-01-11), Heft 2, S. 182academicJournalZugriff:
-
In: Blood, Jg. 127 (2016-05-05), Heft 18, S. 2219academicJournalZugriff:
-
In: Blood, Jg. 127 (2016-03-03), Heft 9, S. 1117academicJournalZugriff:
-
In: Blood, Jg. 125 (2015-05-14), Heft 20, S. 3128academicJournalZugriff:
-
In: Blood, Jg. 120 (2012-07-26), Heft 4, S. 761academicJournalZugriff:
-
In: Blood, Jg. 117 (2011-06-23), Heft 25, S. 6793academicJournalZugriff:
-
In: Blood, Jg. 117 (2011-06-09), Heft 23, S. 6287academicJournalZugriff:
-
In: Blood, Jg. 114 (2009-07-16), Heft 3, S. 719academicJournalZugriff:
-
In: Blood, Jg. 109 (2007-05-15), Heft 10, S. 4143academicJournalZugriff:
-
MEK1/2 inhibitors sensitize Bcr/Abl+ human leukemia cells to the dual Abl/Src inhibitor BMS-354/825.In: Blood, Jg. 109 (2007-05-01), Heft 9, S. 4006academicJournalZugriff:
-
In: Blood, Jg. 109 (2007-03-01), Heft 5, S. 2112academicJournalZugriff: